Log in

FDA Approves Non-Opioid for Opioid Withdrawal

05/21/2018 11:52 AM | Anonymous member (Administrator)

On May 16, 2018, the Food and Drug Administration (FDA) approved Lucemyra (lofexidine hydrochloride) to lessen withdrawal symptoms related to abrupt discontinuation of opioids in adults. Lucemyra is the first non-opioid approved for use in a long term treatment plan for managing opioid use disorder (OUD).  The drug is only approved for treatment for up to 14 days. It is not approved as a stand-alone treatment for OUD. The FDA granted approval of Lucemyra to US WorldMeds, LLC. Read the FDA news release.


Phone - 785-234-5563
Fax - 785-234-5564

Info@kansasdo.org
1260 SW Topeka Blvd.
Topeka, KS 66612

www.kansasdo.org
Powered by Wild Apricot Membership Software